Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository
NCT05100420
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Edmonton, Alberta, Canada
View Trial DetailsNCT Number: NCT06461468
HCM FLIP study is a two-phase protocol focusing on the detection of Hypertrophic Cardiomyopathy using Electrocardiograms and Echocardiograms through Federated Learning.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Thomas Hospital, Fairhope, Alabama, United States
HCM FLIP (Hypertrophic Cardiomyopathy Federated Learning Implementation Platform) aim to build and test a model's system impact to detect hypertrophic cardiomyopathy (HCM) by training a machine learning (ML) model with electrocardiograms (ECGs) and echocardiograms (ECHOs). Approximately 10-1000 HCM cases and 30-10,000 age/sex-matched controls per institution, depending on size, will be included in the study. We hypothesize that a federated ML model will discriminate cases of HCM from those without HCM in a real-world setting.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
HCM-Labeled Case Inclusion Criteria:
HCM-Labeled Case Exclusion Criteria:
Control Case (Non-HCM) Inclusion Criteria:
Control Case (Non-HCM) Exclusion Criteria
Time frame: Through study completion, an average of 2 years
The number/instances of HCM diagnoses as identified by the ML model as compared to clinical diagnosis confirmation. Due to model training and efficacy goals, HCM diagnosis determined clinically via EKG/ECHO reading will be compared to the ML model's capacity to identify HCM correctly and efficiently.
Time frame: Through study completion, an average of 2 years
Diagnosis of different types of HCM (i.e., apical, obstructive), HCM without hypertrophy, genetic positive/negative indicators, among others, as identified by the ML model as compared to clinical diagnosis confirmation. Due to model training and efficacy goals, HCM diagnosis determined clinically via EKG/ECHO reading will be compared to the ML model's capacity to identify HCM correctly and efficiently.
American Heart Association
Other
Detection of Hypertrophic Cardiomyopathy Using Electrocardiograms and Echocardiograms Through Federated Learning
Acronym: HCM FLIP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05100420
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Edmonton, Alberta, Canada
View Trial DetailsNCT03527342
Amyloidosis, Amyloidosis; Heart (Manifestation)
Gothenburg, Sweden
View Trial DetailsNCT02432092
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Indianapolis, Indiana, United States
View Trial DetailsNCT04712136
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Montpellier, Occitanie, France
View Trial Details